Menu
Back to Journals » Drug Design, Development and Therapy » Volume 13
Review
Brigatinib for ALK-positive metastatic non-small-cell lung cancer: design, development and place in therapy
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 11,853 | Dovepress* | 7,975+ | 1,576 | 9,551 | |
| PubMed Central* | 3,878 | 852 | 4,730 | ||
| Totals | 11,853 | 2,428 | 14,281 | ||
| *Since 8 February 2019 | |||||
View citations on PubMed Central and Google Scholar